all report title image

PHARMACOVIGILANCE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Pharmacovigilance Market, By Clinical Trial Phases (Pre-clinical Studies, Clinical Trial Phase I, Clinical Trial Phase II, Clinical Trial Phase III, and Post Marketing Surveillance or Phase IV), By Type of Method (Spontaneous Reporting, Intensified ADR Reporting, Targeted Reporting, Cohort Event Monitoring, and EHR Monitoring), By Type of Service Provider (In-House and Contract Outsourcing), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa)

  • Published In: 01 Apr, 2026
  • Code: CMI1047
  • Page number: 140
  • Formats:   Excel and PDF
  • Industry: Healthcare IT
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Clinical Trial Phases
      • Market Snapshot, By Type of Method
      • Market Snapshot, By Type of Service Provider
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Scenario
    • Acquisitions and Partnerships Scenario
    • Funding and Investments
    • PEST Analysis
    • Porter’s Analysis
  4. Global Pharmacovigilance Market, By Clinical Trial Phases, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Pre-clinical Studies
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Clinical Trial Phase I 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Clinical Trial Phase II  
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Clinical Trial Phase III
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Post Marketing Surveillance or Phase IV
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  5. Global Pharmacovigilance Market, By Type of Method, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • Spontaneous Reporting 
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Intensified ADR Reporting
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Targeted Reporting
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Cohort Event Monitoring
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • EHR Monitoring
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  6. Global Pharmacovigilance Market, By Type of Service Provider, 2021 – 2033, (USD Bn)

    • Overview
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2021 – 2033
      • Segment Trends
    • In-House
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
    • Contract Outsourcing
      • Overview
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
  7. Global Pharmacovigilance Market, By Region, 2021 – 2033, (USD Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2021–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Clinical Trial Phases, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Method, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Type of Service Provider, 2021 - 2033, (USD Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Company Profiles
      • Accenture
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Cognizant Technology Solutions
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Laboratory Corporation of America Holdings (LabCorp)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • IBM Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • QuintilesIMS (IQVIA)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ICON plc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Capgemini
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ITClinical
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • TAKE Solutions Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • BioClinica
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • PAREXEL International Corporation
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Wipro Ltd
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • FMD K&L
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Linical Accelovance
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • United BioSource Corporation (UBC)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • PRA Health Sciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • ArisGlobal
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
      • Ennov Solutions Inc
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Market Strategies
  9. Analyst Recommendations

    • Wheel of Fortune
    • Analyst View
    • Coherent Opportunity Map
  10. References and Research Methodology


    • References
    • Research Methodology
    • About Us and Sales Contact
  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.